🇺🇸 ValACYclovir 1000 MG in United States

10 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Abdominal Pain — 1 report (10%)
  2. Acute Kidney Injury — 1 report (10%)
  3. Back Pain — 1 report (10%)
  4. Drug Ineffective — 1 report (10%)
  5. Flank Pain — 1 report (10%)
  6. Hypersensitivity — 1 report (10%)
  7. Intestinal Congestion — 1 report (10%)
  8. Oral Mucosal Blistering — 1 report (10%)
  9. Pruritus — 1 report (10%)
  10. Pyrexia — 1 report (10%)

Source database →

ValACYclovir 1000 MG in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is ValACYclovir 1000 MG approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for ValACYclovir 1000 MG in United States?

Vanderbilt University Medical Center is the originator. The local marketing authorisation holder may differ — check the official source linked above.